Free Trial
OTCMKTS:GRRMF

Gerresheimer (GRRMF) Stock Price, News & Analysis

Gerresheimer logo
$90.30 0.00 (0.00%)
(As of 11/20/2024 ET)

About Gerresheimer Stock (OTCMKTS:GRRMF)

Key Stats

Today's Range
$90.30
$90.30
50-Day Range
$82.40
$114.50
52-Week Range
$82.40
$117.47
Volume
N/A
Average Volume
673 shs
Market Capitalization
N/A
P/E Ratio
39.78
Dividend Yield
0.57%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Receive GRRMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

GRRMF Stock News Headlines

Gerresheimer (0NTI) Gets a Buy from Kepler Capital
J.P. Morgan Reaffirms Their Buy Rating on Gerresheimer (0NTI)
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
Gerresheimer (0NTI) Receives a Buy from Kepler Capital
EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025
See More Headlines

GRRMF Stock Analysis - Frequently Asked Questions

Gerresheimer's stock was trading at $102.60 at the start of the year. Since then, GRRMF shares have decreased by 12.0% and is now trading at $90.30.
View the best growth stocks for 2024 here
.

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:GRRMF
CIK
N/A
Fax
N/A
Employees
11,947
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:GRRMF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners